Sivem Pharmaceuticals ULC is recalling one lot of Sivem ezetimibe 10 mg tablets because some bottles may also contain perindopril 4 mg tablets. Taking perindopril when prescribed ezetimibe may ...

A new study found that adding a second drug early after a heart attack may save lives. Those who added ezetimibe to a statin had fewer complications and deaths. The authors say that early ...

A Swedish database of over 35,000 individuals found better cardiovascular outcomes when ezetimibe was added earlier to statin therapy for secondary prevention. Study authors deemed ezetimibe a ...

However, with the long half-life of ezetimibe (22 hours), the effect of the time of administration on the efficacy of combined therapy of ezetimibe with simvastatin has not been established.

Effects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy ...

The effect of statin therapy in combination with ezetimibe on circulating C-reactive protein levels: a systematic review and meta-analysis of randomized controlled trials.

NEXLETOL (bempedoic acid) for the Treatment of Heterozygous Familial Hypercholesterolemia (HeFH), USA NEXLETOL® (bempedoic acid) and its combination with ezetimibe NEXLIZET® are oral non-statin ...

The following are key points to remember from a review article on a stepwise approach to prescribing novel lipid-lowering therapies: Ezetimibe should be added if LDL-C is ≥70 mg/dL on maximally ...

The results suggest that this approach, using biomarkers like C-reactive protein (CRP) and high-sensitivity cardiac troponin T (hs-cTnT), could identify higher-risk patients in the post-ACS setting.

Compared with placebo or either agent alone, a combination of bempedoic acid and ezetimibe lowered LDL to a greater degree, researchers reported.The researchers also wrote that the combination was ...

Association Between Baseline, Achieved, and Reduction of CRP and Cardiovascular Outcomes After LDL Cholesterol Lowering with Statins or Ezetimibe: A Systematic Review and Meta‐Analysis ...